申请人:EpiTherapeutics ApS
公开号:US20140371214A1
公开(公告)日:2014-12-18
Compounds of the form
In which Q is selected from —CH═NR
12
, —W, —CH
2
NHR
13
, —CH═O and —CH(OR
17
)
2
capable of modulating the activity of histone demethylases (HDMEs), which are useful for prevention and/or treatment of diseases in which genomic dysregulation is involved in the pathogenesis, such as e.g. cancer and formulations and methods of use of such compounds.
以下为翻译结果:
化合物的形式为Q为选自—CH═NR12、—W、—CH2NHR13、—CH═O和—CH(OR17)2,能够调节组蛋白去甲基化酶(HDMEs)的活性,这对于预防和/或治疗基因组失调参与病理发生的疾病,例如癌症,以及这些化合物的制剂和使用方法是有用的。